exploring the biological mechanisms driving mbl progression to cll
Published 1 month ago • 47 plays • Length 1:01Download video MP4
Download video MP3
Similar videos
-
1:10
the pathways of cll pathogenesis and cll’s relationship with mbl
-
2:20
barriers to the implementation of mrd-guided treatment into cll clinical practice
-
1:43
exploring the role of non-coding rnas in cll biology
-
1:12
insights into the optimal management of cll: the importance of patient characteristics
-
0:54
the role of metabolic programming in cll biology and the importance of studying lymph node cells
-
2:08
an insight into the current understanding of risk factors for cll
-
1:35
the future directions of cll research: mechanisms of pathogenesis and novel biomarkers
-
1:39
the importance of diagnostic testing in cll
-
43:59
dr david spaner - cll diagnosis and managing symptoms
-
4:40
inside the lmb: one take fly through
-
9:25
unveiling the power of nivolumab: how it works, uses, and potential side effects
-
2:44
the structure and function of bcrs in the biology of cll
-
2:34
a study investigating the three-dimensional structure and interactions of bcrs in cll
-
3:59
using an ipsc-derived model to understand the mechanisms driving light chain-induced cardiotoxicity
-
2:09
real-world incidence of ibrutinib-related cardiotoxicity in cll: insights from the lls registry
-
1:11
genomic testing can help identify patient risk factors and guide clinical decision-making
-
3:09
retrospective analysis of clinical outcomes in pts with lbcl receiving car-t or autosct while in cr
-
1:13
monitoring patients with cll on ibrutinib-based therapies
-
0:50
siltuximab for the management of car-t toxicities: a multicenter retrospective study
-
1:48
studying the mechanical properties of cll cells
-
1:13
overcoming car-t resistance in cll: combining with ibrutinib